Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007–2011
Open Access
- 11 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12), e51653
- https://doi.org/10.1371/journal.pone.0051653
Abstract
Influenza viral shedding studies provide fundamental information for preventive strategies and modelling exercises. We conducted a prospective household study to investigate viral shedding in seasonal and pandemic influenza between 2007 and 2011 in Berlin and Munich, Germany. Study physicians recruited index patients and their household members. Serial nasal specimens were obtained from all household members over at least eight days and tested quantitatively by qRT-PCR for the influenza virus (sub)type of the index patient. A subset of samples was also tested by viral culture. Symptoms were recorded daily. We recruited 122 index patients and 320 household contacts, of which 67 became secondary household cases. Among all 189 influenza cases, 12 were infected with seasonal/prepandemic influenza A(H1N1), 19 with A(H3N2), 60 with influenza B, and 98 with A(H1N1)pdm09. Nine (14%) of 65 non-vaccinated secondary cases were asymptomatic/subclinical (0 (0%) of 21 children, 9 (21%) of 44 adults; p = 0.03). Viral load among patients with influenza-like illness (ILI) peaked on illness days 1, 2 or 3 for all (sub)types and declined steadily until days 7–9. Clinical symptom scores roughly paralleled viral shedding dynamics. On the first day prior to symptom onset 30% (12/40) of specimens were positive. Viral load in 6 asymptomatic/subclinical patients was similar to that in ILI-patients. Duration of infectiousness as measured by viral culture lasted approximately until illness days 4–6. Viral load did not seem to be influenced by antiviral therapy, age or vaccination status. Asymptomatic/subclinical infections occur infrequently, but may be associated with substantial amounts of viral shedding. Presymptomatic shedding may arise in one third of cases, and shedding characteristics appear to be independent of (seasonal or pandemic) (sub)type, age, antiviral therapy or vaccination; however the power to find moderate differences was limited.Keywords
This publication has 36 references indexed in Scilit:
- Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus InfectionPLOS ONE, 2011
- Pandemic (H1N1) 2009 Transmission during Presymptomatic Phase, JapanEmerging Infectious Diseases, 2011
- Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a reviewInfluenza and Other Respiratory Viruses, 2011
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge StudiesAmerican Journal of Epidemiology, 2008
- Strategies for mitigating an influenza pandemicNature, 2006
- Strategies for containing an emerging influenza pandemic in Southeast AsiaNature, 2005
- Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human InfluenzaJama-Journal Of The American Medical Association, 1999
- Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathyJournal of Medical Virology, 1999
- Correlated Studies of a Recombinant Influenza-Virus Vaccine. III. Protection against Experimental Influenza in ManThe Journal of Infectious Diseases, 1971
- Proved viraemia in asian influenza (Hong Kong variant) during incubation periodBMJ, 1969